| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 05/15/2007 | US7217552 expression vector; host cell transformed with gene; culturing cell to produce polypeptide that has an activity of converting a sulfated fucogalactan into a smaller molecule |
| 05/15/2007 | US7217549 enzyme involved in synthesis of lipooligosaccharides including gangliosides and ganglioside mimics; campylobacter jujuni (C. jejuni) |
| 05/15/2007 | US7217548 N-acetylglucosaminlytransferase and polynucleotide encoding the same |
| 05/15/2007 | US7217544 with recombinant microorganism transformed with polynucleotides encoding the enzymes: D-amino acid oxidase; L-amino acid dehydrogenase, and an enzyme that regenerates NADH; overexpression |
| 05/15/2007 | US7217543 Method for producing L-amino acid using methylotroph |
| 05/15/2007 | US7217541 Culuring transgenic cells which codes bactericides; genetic vaccines |
| 05/15/2007 | US7217538 Nucleic acid molecule containing a nucleotide sequence encoding CaEss1 (candida albicans) gene or having at least 70% homology; antiproliferative application |
| 05/15/2007 | US7217536 Medium and method for detecting/identifying microorganisms |
| 05/15/2007 | US7217535 Immunoassay diagnosis of susceptibility to atherosclerosis by analyzing blood for presence of enzyme using polyclonal or monoclonal antibodies; elevated levels are indicative of susceptibility |
| 05/15/2007 | US7217528 isolated antibody that specifically binds to polypeptides for diagnosing, preventing and treating autoimmune, cancer and transplant disorders; wound healing agents |
| 05/15/2007 | US7217522 extending a primer annealed to polynucleotides having predetermined sequence characteristics to incorporate a predetermined terminator having a capture moiety; capturing; melting the captured polynucleotides from the extended primer |
| 05/15/2007 | US7217513 Apparatus and method for isolating a nucleic acid from a sample |
| 05/15/2007 | US7217511 Methods of increasing antibiotic production in Streptomyces by deletion of the scbA gene |
| 05/15/2007 | US7217420 Protective formulation that prevents virulent Mycoplasma gallisepticum infection in birds of the order Galliformes; formulation comprises a protective amount of live MG strain K5054 or derivatives |
| 05/15/2007 | US7217415 NADP-dependent glyceraldehyde-3-phosphate dehydrogenase for therapeutic use |
| 05/15/2007 | US7217414 Methods of preventing peritonitis by administering lactic acid bacterium |
| 05/15/2007 | US7217412 IL-17C related mammalian cytokine polypeptides |
| 05/15/2007 | CA2404293C Variants of an erwinia-type creatinase |
| 05/15/2007 | CA2394616C Gene cluster for ramoplanin biosynthesis |
| 05/15/2007 | CA2324649C Human p51 genes and gene products thereof |
| 05/15/2007 | CA2279919C Arthrobacter vaccine and its use against renibacterium salmoninarum |
| 05/15/2007 | CA2260940C Methods for isolating nucleic acids using alkaline protease |
| 05/15/2007 | CA2250234C Novel plant acetylenase and use thereof |
| 05/15/2007 | CA2198965C Method for culturing microorganisms having methanol metabolic pathway |
| 05/15/2007 | CA2196100C Saccharomyces treatment to diminish campylobacter and salmonella populations in poultry |
| 05/15/2007 | CA2149922C Genetically engineered glutaminase and its use in antiviral and anticancer therapy |
| 05/15/2007 | CA2089391C Gram-positive alkaliphilic microorganisms |
| 05/15/2007 | CA2087958C Transferrin binding proteins from neisseria gonorrhoeae and neisseria meningitidis |
| 05/15/2007 | CA2011633C Intercellular adhesion molecule - 2 and its binding ligands |
| 05/10/2007 | WO2007053731A2 Expression of soluble factor viii proteins in bacteria |
| 05/10/2007 | WO2007053489A2 Attenuated salmonella enterica serovar paratyphi a and uses thereof |
| 05/10/2007 | WO2007052643A1 Lactic acid bacterium having immunoregulatory activity derived from moromi for wine fermentation |
| 05/10/2007 | WO2007052168A2 Fed batch culture methods for streptococci |
| 05/10/2007 | WO2007052081A2 Bacterial growth enhancer |
| 05/10/2007 | WO2007051836A2 Compositions for treating dermatological and neurological disorders |
| 05/10/2007 | WO2007051651A1 INDUSTRIAL PRODUCING STRAIN OF THE FUNGUS CLAVICEPS PURPUREA (Fr.) Tul. |
| 05/10/2007 | WO2007033256A3 Biodegradation of subsurface contaminants by injection of gaseous microbial metabolic inducer |
| 05/10/2007 | WO2007030830A9 Methods and organisms for the growth-coupled production of succinate |
| 05/10/2007 | WO2006138225B1 A novel and practical serological assay for the clinical diagnosis of leishmaniasis |
| 05/10/2007 | WO2006113147A3 Ascorbic acid production from d-glucose in yeast |
| 05/10/2007 | WO2006044290A8 Biosynthesis of philoroglucinol and preparation of 1,3-dihydroxybenzene therefrom |
| 05/10/2007 | WO2006007124A3 Nucleic acid sequences encoding cel ii endonuclease |
| 05/10/2007 | WO2005113776A3 Expression cassette |
| 05/10/2007 | US20070107080 Production of 3-hydropropionic acid using beta-alanine/pyruvate aminotransferase |
| 05/10/2007 | US20070106068 Nucleotide sequences coding Zcytor16 specific immunoglobulin for use in prevention and treatment of nervous system, inflammatory and autoimmune disorders |
| 05/10/2007 | US20070106062 Attenuated vif DNA immunization cassettes for genetic vaccines |
| 05/10/2007 | US20070105777 For detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells |
| 05/10/2007 | US20070105771 Anti-CD26 antibodies and methods of use thereof |
| 05/10/2007 | US20070105754 Pharmaceutical composition to prevent and treat epithelial wounds, immunomodulating pharmaceutical composition, pharmaceutical composition, insecticide, insecticide composition insecticide use of lectin KM+ to treat cicatrizations, use of lectin KM+ to prepare immunomodulating medicament, use of lectin KM+ to prepare anti-bacterial medicament, use lectin KM+ to prpare anti-viral medicament, use of lectin KM+ to prepare anti-parasite medicament, use of lectin KM+ to prepare anti-fungal medicament, use of lectin KM+ to prepare anti-parasite medicament expression method, DNA vector, recombinant |
| 05/10/2007 | US20070105225 DNA and proteins or peptides specific of bacteria of the Neisseria meningitidis species, methods for obtaining them and biological applications thereof |
| 05/10/2007 | US20070105209 Feed additives for reducing odor of animal waste products |
| 05/10/2007 | US20070105203 Enterobacteriaceae fermentation strains |
| 05/10/2007 | US20070105202 Dna encoding a protein having d-lactate dehydrogenase activity and uses thereof |
| 05/10/2007 | US20070105197 Nucleic acid fragments encoding nitrile hydratase and amidase enzymes from Comamonas testosteroni 5-MGAM-4D and recombinant organisms expressing those enzymes useful for the production of amides and acids |
| 05/10/2007 | US20070105191 Capable of inducing chondrocyte proliferation; Chinese Hamster Ovary, an Escheria coli or a yeast host cell with an expression vector |
| 05/10/2007 | US20070105186 Method for preserving microbial cells |
| 05/10/2007 | US20070105174 Novel glucose dehydrogenase |
| 05/10/2007 | US20070105173 Modified pyrroloquinoline quinone (pqq) dependent glucose dehydrogenase excellent in substrate specificity |
| 05/10/2007 | US20070105167 Virulence Associated Nucleic Acid Sequences and Uses Thereof |
| 05/10/2007 | US20070105154 Cell lysis composition, methods of use, apparatus, and kit |
| 05/10/2007 | US20070105153 Maternal Antigen That Embryos Require (MATER); Recognizing epitope by detecting binding; indicative of infertility |
| 05/10/2007 | US20070105143 Novel bHLH type transcription factor genes |
| 05/10/2007 | US20070105127 DNA libraries comprising vector constructs coding glycosylation enzymes and organelle targeting signal sequences for use in modifying exogenously expressed polypeptides |
| 05/10/2007 | US20070105122 Primers for synthesizing full-length cDNA and their use |
| 05/10/2007 | US20070105117 Method for in vitro evolution of polypeptides |
| 05/10/2007 | US20070105115 Promoter of the human fatp5 gene and uses |
| 05/10/2007 | US20070105112 Laccases, nucleic acids encoding them and methods for making and using them |
| 05/10/2007 | US20070105106 Methods and reagents for quantitative analysis of Dehalococcoides species |
| 05/10/2007 | US20070105098 Isolation and use of ryanodine receptors |
| 05/10/2007 | US20070104834 An isolated aspartic protease of Aspergillus or Penicillium, and used in both milk clotting and cheese preparation; screening amino acid sequences for the presence of Phe-Asp-Tyr-Gly-Ser-Ser-Asp or Phe-Asp-Tyr-Gly-Ser-Ser-Glu; nucleic acids, expression vectors, host cells |
| 05/10/2007 | US20070104764 Recombinant production of antimicrobial peptides |
| 05/10/2007 | US20070104738 Extracellular vesicles from non-pathogenic amoebae useful as vehicle for transferring a molecule of interest to an eukaryotic cell |
| 05/10/2007 | US20070104737 Recombinant light chains of botulinum neurotoxins and light chain fusion proteins for use in research and clinical therapy |
| 05/10/2007 | US20070104736 Culturing a non-typeable Haemophilus influenzae strain having a mutation in htrB gene, wherein the htrB mutation produces a mutant non-typeable Haemophilus influenzae; purifying the mutant endotoxin |
| 05/10/2007 | US20070104726 Multimeric complexes of antigens and adjuvants |
| 05/10/2007 | US20070104724 Attaching substances to microorganisms |
| 05/10/2007 | US20070104713 Nogo receptor homologs |
| 05/10/2007 | DE102005051789A1 Der Botulinus Neurotoxin A Proteinrezeptor und seine Anwendungen The botulinum neurotoxin A receptor protein and its applications |
| 05/10/2007 | CA2627976A1 Fed batch culture methods for streptococci |
| 05/10/2007 | CA2627897A1 Bacterial growth enhancer |
| 05/10/2007 | CA2626909A1 Microorganism and process for the preparation of l-methionine |
| 05/10/2007 | CA2626114A1 Attenuated salmonella enterica serovar paratyphi a and uses thereof |
| 05/09/2007 | EP1783227A1 Humanized anti-CCR2 antibodies and methods of use therefor |
| 05/09/2007 | EP1783226A1 AAV structural protein, production and use thereof |
| 05/09/2007 | EP1783225A1 AAV structural protein, production and use thereof |
| 05/09/2007 | EP1783223A1 Fungal transcriptional activator PRTT from Aspergillus niger, useful in methods for producing polypeptides |
| 05/09/2007 | EP1783222A1 Dimeric thrombopoietin peptide mimetics binding to MP1 receptor and having thrombopoietic activity. |
| 05/09/2007 | EP1783221A1 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor |
| 05/09/2007 | EP1783219A1 Method of searching for novel drug discovery targets |
| 05/09/2007 | EP1783217A1 Stabilized proline transporter |
| 05/09/2007 | EP1783209A1 Selective culture method and separation method for small hepatocytes with the use of hyaluronic acid |
| 05/09/2007 | EP1783203A1 Process for producing substances |
| 05/09/2007 | EP1783141A1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 05/09/2007 | EP1783139A2 Human telomerase catalytic subunit |
| 05/09/2007 | EP1782806A1 Compositions for treating dermatological and neurological disorders |
| 05/09/2007 | EP1781797A2 Mutant e. coli strain with increased succinic acid production |
| 05/09/2007 | EP1781790A2 Alpha-amylase variants with altered properties |
| 05/09/2007 | EP1781788A2 Chicken deoxycytidine and deoxyadenosine kinase enzymes and their use |
| 05/09/2007 | EP1781781A2 Nucleic acid sequences encoding cel ii endonuclease |
| 05/09/2007 | EP1781773A1 A micro-organism and a method of producing paclitaxel by the use of the same |